May 31, 2016 New drugs are on the horizon for the treatment of severe eczema. FDA could approve at least two new eczema medications in 2017, while six more treatments are undergoing clinical tests. Eczema affects about 12% of children in the United States and 7%–10% of adults, according to estimates.
New drugs are on the horizon for the treatment of severe eczema. FDA could approve at least two new eczema medications in 2017, while six more treatments are undergoing clinical tests. Eczema affects about 12% of children in the United States and 7%–10% of adults, according to estimates. While the condition is most common in children and often disappears on its own prior to adolescence, many adults also have eczema, including some 1.6 million with severe forms of the disease that can negatively affect their emotional and mental health.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.